Glycative stress and anti-aging : 2. The Evaluation of Glycative Stress : Measurement of blood glucose, glycated proteins and intermediates.

アブストラクト

Title	Glycative stress and anti-aging : 2. The Evaluation of Glycative Stress : Measurement of blood glucose, glycated proteins and intermediates.
Subtitle	Review article
Authors	Masayuki Yagi, Yoshikazu Yonei
Authors (kana)
Organization	Anti-Aging Medical Research Center and Glycative Stress Research Center, Faculty of Life and Medical Sciences, Doshisha University
Journal	Glycative Stress Research
Volume	3
Number	4
Page	205-209
Year/Month	2016 /
Article	Report
Publisher	Glycative Stress Research
Abstract	[Abstract] Various substances produced in the course of glycation reaction can be used as markers for the evaluation of glycative stress. The glycative stress markers in the stage before the productio... 続きをご覧いただくにはログインが必要です。・アブストラクト：無料ログイン画面にすすむ
Practice	General medicine
Keywords	Glycative stress marker, measurement method, blood glucose, glycated protein, intermediates for AGEs

1) Benjamin EM, Self-monitoring of blood glucolse:The basics. Clinical Diabetes. 2002;20:45-47.
2) Taguchi T, Yamaoka H. Application of the biosensor in a clinical examination:For an example about a glucose sensor. KAGAKU TO SEIBUTSU. 2006;44:192-197. (in Japanese)
3) Uchikata Y. Before self-monitoring of blood glucose:The reconsideration about a dissolved oxygen or an interfering substance. CDEJ News Letter. 2007;15:7. (in Japanese)
4) Yamada S. Historical achievements of self-monitoring of blood glucose technology development in Japan. J Diabetes Sci Technol. 2011;5:1300-1306.
pubmed
5) Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care. 1995;18:440-447.
pubmed

残りの7件を表示する

6) Weykamp C, John WG, Mosca A. A review of the challenge in measuring hemoglobin A1c. J Diabetes Sci Technol. 2009;3:439-445.
pubmed
7) Goodall I. HbA1c Standardisation Destination-Global IFCC Standardisation How, Why, Where and When. Clin Biochem Rev. 2005;26:5-19.
pubmed
8) Ibreg N, Fliick R. Nonenzymatic glycosylation of albumin in vivo. J Biol Chem. 1986;261:13542-13545.
9) Takeuchi M, Yamagishi S. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease. J Alzheimers Dis. 2009;16:845-858.
10) Kusunoki H, Miyata S, Ohara T, et al. Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy. Diabetes Care. 2003;26:1889-1894.
pubmed
11) Takeuchi M. TAGE(toxic AGEs)hypothesis in life style-related disease. Bulletin of Hokuriku University. 28;2004;33-48. (in Japanese)
12) Yamada H, Miyata S, Igaki N, et al. Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction. J Biol Chem. 1994;269:20275-20280.
pubmed